Quotes 5-day view Delayed Nasdaq
Estimated financial data (e) (USD)
Net income 2021
Net cash position 2021
P/E ratio 2021
Net income 2022
Net cash position 2022
P/E ratio 2022
EV / Sales 2021
EV / Sales 2022
Nbr of Employees
Sensei Biotherapeutics, Inc. is a clinical-stage immunotherapy company. The Company is engaged in the discovery and development of therapies with focus on treatments for cancer. Its ImmunoPhage platform is a self-adjuvanted and differentiated immunotherapy approach that is designed to utilize bacteriophage to induce a robust, focused and coordinated innate and adaptive immune response. The Company is engineering its...
Ratings of Sensei Biotherapeutics, Inc.
All news about SENSEI BIOTHERAPEUTICS, INC.
09/08 SENSEI BIOTHERAPEUTICS, INC. : Regulation FD Disclosure, Financial Statements and Exhibits..
08/11 SENSEI BIOTHERAPEUTICS : Management's Discussion and Analysis of Financial Condition and R..
08/04 SENSEI BIOTHERAPEUTICS : Reports Second Quarter 2021 Results and Highlights (Form 8-K)
08/04 SENSEI BIOTHERAPEUTICS, INC. : Results of Operations and Financial Condition, Financial St..
08/04 Sensei Biotherapeutics, Inc. Reports Earnings Results for the Second Quarter Ended June..
08/04 Sensei Biotherapeutics Reports Second Quarter 2021 Results and Highlights Recent In Viv..
08/02 SENSEI BIOTHERAPEUTICS : Departure of Directors or Certain Officers; Election of Directors..
08/02 SENSEI BIOTHERAPEUTICS, INC. : Change in Directors or Principal Officers (form 8-K)
08/02 Sensei Biotherapeutics, Inc. Appoints Kristian Humer as Director and as Member of the i..
08/02 SENSEI BIOTHERAPEUTICS : Appoints Kristian Humer to its Board of Directors
08/02 Certain Warrants of Sensei Biotherapeutics, Inc. are subject to a Lock-Up Agreement End..
08/02 Certain Stock Options of Sensei Biotherapeutics, Inc. are subject to a Lock-Up Agreemen..
08/02 Certain Common Stock of Sensei Biotherapeutics, Inc. are subject to a Lock-Up Agreement..
07/06 SENSEI BIOTHERAPEUTICS : Piper Sandler Adjusts Price Target on Sensei Biotherapeutics to $..
07/01 SENSEI BIOTHERAPEUTICS : Berenberg Downgrades Sensei Biotherapeutics to Hold from Buy, Set..
News in other languages on SENSEI BIOTHERAPEUTICS, INC.
Analyst Recommendations on SENSEI BIOTHERAPEUTICS, INC.
Chart SENSEI BIOTHERAPEUTICS, INC.
Technical analysis trends SENSEI BIOTHERAPEUTICS, INC.
Short Term Mid-Term Long Term Trends Neutral Neutral Neutral
Number of Analysts
Last Close Price
Average target price
Spread / Average Target